Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Evaluation of serum hepcidin concentrations in patients with obstructive sleep apnea
11th International Conference on Vascular Dementia
Manolov V, Georgiev O, Vasilev V, Pencheva-Genova V, Grozdanova R, Traykov L, Petrova I, Tzatchev K, Hadjidekova S,Karadjova M, Voleva S, Nikolova M, Angov G, Petrova-Ivanova I, Kunchev T, Ovcharov D and Gramatikova Z
Medical University-Sofia, BulgariaUniversity Aleksandrovska Hospital, BulgariaNCIPD, BulgariaR.E.D Laboratories, Belgium
Obstructive sleep apnea syndrome (OSA) is defined as a combination of symptoms as a result of intermittent, recurrent constraint
and/or complete airway overhead/ airway overflow (sleep disturbance). In the case of reduced airflow through upper respiratory
tract >90%, in the presence of thoracic and/or abdominal movements over a period >10 sec., it is about obstructive apnea. With
a ≥30% reduced airflow over the upper respiratory tract over a period of 10 seconds, desaturation ≥3% followed by waking or
desaturation >4%. During desaturation episodes, the organism is subjected to chronic stress. This leads to reduced nitric oxide
secretion, increased release of interleukin-6, tumor necrosis factor-alpha and other pro-inflammatory cytokines. The described
pathological cascades are associated with the development of insulin resistance, arterial hypertension, metabolic syndrome, systemic
atherosclerosis and increased cardiovascular risk. Thirty five (35) patients with OSA were included; age 42.9±8.8. The established
results were compared to sex and age matched healthy control and with patients with no atherosclerotic changes. Routine blood
analyses as CBC, serum iron, ferritin, hsCRP and specific hepcidin, homocysteine and vitamin B12 were measured in the included
groups. IMT and FMT were used for atherosclerotic changes evaluation. We found increased serum hepcidin levels in OSA patients
with IMT and FMD changes (99.1±14.7 μg/L) compared to healthy controls (19.5±2.1 µg/L); P<0.001. A positive correlation was
found in OSA patients with atherosclerotic changes between IMT and FMD to serum hepcidin levels (r=0.809, r=0.877, resp.;
P<0.01). Serum hepcidin correlates positively to homocysteine in OSA patients with atherosclerotic evidence changes (r=0.899,
P<0.005). Brain-vascular disease risk factors are connected to obstructive sleep apnea syndrome. Dysregulation of iron homeostasis
is one of the main risk atherogenesis factors. Early hepcidin quantification might predict an atherosclerosis occurrence in OSA
patients, which might be very important for better clinical diagnosis and practice
Biography
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals